- Company Overview for DXCOVER SUB LIMITED (SC688317)
- Filing history for DXCOVER SUB LIMITED (SC688317)
- People for DXCOVER SUB LIMITED (SC688317)
- More for DXCOVER SUB LIMITED (SC688317)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
29 Mar 2024 | AA | Accounts for a dormant company made up to 31 December 2023 | |
01 Mar 2024 | TM01 | Termination of appointment of Mark Hegarty as a director on 29 February 2024 | |
01 Mar 2024 | AP01 | Appointment of Dr Matthew Baker as a director on 29 February 2024 | |
05 Feb 2024 | CS01 | Confirmation statement made on 4 February 2024 with no updates | |
27 Apr 2023 | AA | Accounts for a dormant company made up to 31 December 2022 | |
06 Feb 2023 | CS01 | Confirmation statement made on 4 February 2023 with updates | |
13 Jul 2022 | AA | Accounts for a dormant company made up to 31 December 2021 | |
21 Apr 2022 | AA01 | Previous accounting period shortened from 28 February 2022 to 31 December 2021 | |
04 Feb 2022 | CS01 | Confirmation statement made on 4 February 2022 with no updates | |
04 Feb 2022 | PSC05 | Change of details for Clinspec Diagnostics Limited as a person with significant control on 26 April 2021 | |
26 Apr 2021 | RESOLUTIONS |
Resolutions
|
|
05 Mar 2021 | AD01 | Registered office address changed from 99 Dr Matthew Baker, Tic Level 7 99 George Street Glasgow G1 1rd Scotland to Suite Rc534, Royal College Building 204 George Street Glasgow G1 1XW on 5 March 2021 | |
05 Mar 2021 | AP01 | Appointment of Dr Mark Hegarty as a director on 5 March 2021 | |
05 Feb 2021 | NEWINC |
Incorporation
Statement of capital on 2021-02-05
|